Literature DB >> 24716598

Decreased expression of Runx1 and lowered proportion of Foxp3⁺ CD25⁺ CD4⁺ regulatory T cells in systemic sclerosis.

Hiroshi Kataoka1, Shinsuke Yasuda, Shinji Fukaya, Kenji Oku, Tetsuya Horita, Tatsuya Atsumi, Takao Koike.   

Abstract

OBJECTIVES: To investigate the role of Foxp3(+) CD25(+) CD4(+) regulatory T cells (Treg) and their transcription factor, Runt-related transcription factor 1 (Runx1), in the pathogenesis and development of systemic sclerosis (SSc).
METHODS: We collected 23 blood samples from patients with SSc including 19 females and 4 males, 11 early-stage cases within 3 years from onset and 12 late-stage cases and 22 samples from age-matched healthy subjects (HS). Total CD4(+) T cells were assessed for the expression of Treg-related markers, CD25 and CD127, on their surface and intracellular Foxp3 using flow cytometry. Relative expression of Runx1 mRNA in magnetically purified Treg was analyzed using real-time PCR.
RESULTS: Proportion of Foxp3(+) cells in total CD4(+) T cells was decreased in patients with either early- or late-stage SSc compared with that in HS, and Runx1 mRNA expression in purified Treg was lower in patients with SSc than in HS. Runx1 mRNA expression level was related to the frequency of Treg in SSc.
CONCLUSIONS: This is the first report on Runx1 expression in Treg of a human autoimmune disease. Low expression of Runx1 along with reduced proportion of Treg in CD4(+) T cells may be associated with development of SSc even in early disease.

Entities:  

Keywords:  Foxp3; Regulatory T cell; Runx1; Systemic sclerosis

Mesh:

Substances:

Year:  2014        PMID: 24716598     DOI: 10.3109/14397595.2014.899736

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  14 in total

Review 1.  Treg cells in autoimmunity: from identification to Treg-based therapies.

Authors:  Lisa Göschl; Clemens Scheinecker; Michael Bonelli
Journal:  Semin Immunopathol       Date:  2019-04-05       Impact factor: 9.623

Review 2.  Regulatory T Cell Plasticity and Stability and Autoimmune Diseases.

Authors:  Runze Qiu; Liyu Zhou; Yuanjing Ma; Lingling Zhou; Tao Liang; Le Shi; Jun Long; Dongping Yuan
Journal:  Clin Rev Allergy Immunol       Date:  2020-02       Impact factor: 8.667

Review 3.  The Pathophysiological Roles of Regulatory T Cells in the Early Phase of Systemic Sclerosis.

Authors:  Satomi Kobayashi; Yasuo Nagafuchi; Hirofumi Shoda; Keishi Fujio
Journal:  Front Immunol       Date:  2022-05-24       Impact factor: 8.786

Review 4.  Epigenetic Variability of CD4+CD25+ Tregs Contributes to the Pathogenesis of Autoimmune Diseases.

Authors:  Ye Shu; Qinghua Hu; Hai Long; Christopher Chang; Qianjin Lu; Rong Xiao
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

5.  Regulatory T cells in skin are uniquely poised to suppress profibrotic immune responses.

Authors:  Lokesh A Kalekar; Jarish N Cohen; Nicolas Prevel; Priscila Muñoz Sandoval; Anubhav N Mathur; Joshua M Moreau; Margaret M Lowe; Audrey Nosbaum; Paul J Wolters; Anna Haemel; Francesco Boin; Michael D Rosenblum
Journal:  Sci Immunol       Date:  2019-09-06

Review 6.  Regulatory T Cells in Systemic Sclerosis: a Comprehensive Review.

Authors:  Gleb Slobodin; Doron Rimar
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

Review 7.  Engineered antigen-specific regulatory T cells for autoimmune skin conditions.

Authors:  Zhussipbek Mukhatayev; Yekaterina O Ostapchuk; Deyu Fang; I Caroline Le Poole
Journal:  Autoimmun Rev       Date:  2021-01-18       Impact factor: 17.390

8.  Meta-analysis of the changes of peripheral blood regulatory T cell to CD4+ T cell ratio in patients with systemic sclerosis.

Authors:  Chuiwen Deng; Wenli Li; Si Chen; Yongzhe Li
Journal:  Sci Rep       Date:  2017-03-02       Impact factor: 4.379

9.  Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment.

Authors:  Tomoaki Higuchi; Kae Takagi; Akiko Tochimoto; Yuki Ichimura; Takanari Norose; Yasuhiro Katsumata; Ikuko Masuda; Hisashi Yamanaka; Toshiro Morohoshi; Yasushi Kawaguchi
Journal:  Arthritis Res Ther       Date:  2019-04-18       Impact factor: 5.156

Review 10.  Regulatory T Cells in Systemic Sclerosis.

Authors:  Camelia Frantz; Cedric Auffray; Jerome Avouac; Yannick Allanore
Journal:  Front Immunol       Date:  2018-10-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.